Table 1.
Group | N | Dose(mg/kg) | AST(U/I) | ALT(U/I) |
---|---|---|---|---|
normal |
8 |
— |
99.0 ± 15.8 |
44.6 ± 10.6 |
CCl4 |
8 |
— |
271.3 ± 142.0△ △ |
209.5 ± 153.9△ △ |
Silymarin |
8 |
100 |
133.8 ± 49.9 ** |
80.4 ± 40.5 * |
BB |
8 |
10 |
202.5 ± 205.5 |
237.8 ± 383.2 |
BB |
8 |
30 |
123.8 ± 17.7 ** |
63.9 ± 49.6 ** |
BB |
8 |
90 |
119.0 ± 58.6 * |
63.9 ± 37.3 ** |
BB |
8 |
270 |
123.8 ± 22.0** |
45.5 ± 12.0** |
BB | 8 | 810 | 127.3 ± 56.4 ** | 59.3 ± 25.3 ** |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.